Significant Revenue Growth
BioLargo achieved an overall sales and revenue increase of 45%, reaching nearly $18 million. The growth was driven by various subsidiaries, showcasing an accelerated growth path.
Impressive Subsidiary Performance
Odor-No-More saw a revenue increase of 36%, generating $5.9 million in operating income. The engineering division also experienced revenue growth of 183%.
Positive Balance Sheet Developments
BioLargo reported a strong balance sheet, maintaining $3.5 million in cash, increased accounts receivable due to business development, and reduced overall debt.
Pooph Product Success
The Pooph product line, with eight unique products and 15 SKUs, has been performing exceptionally well in retail, contributing significantly to revenue growth.
Clyra Medical Nearing Market Readiness
Clyra Medical is approaching the launch of its innovative product, with significant investments in manufacturing and a successful inspection confirming scale capability.